A study in human patients with coronary artery disease identified the mir-487b as a biomarker for recurrent myocardial infarction risk, finding it was downregulated in whole blood of patients with recurrent MI after percutaneous coronary intervention, though it was not significantly different in plasma [Onuoha et al. DOI:10.1111/cts.13307]. Another study in human myocardial biopsies found the mir-487b was upregulated in volume overload cardiomyopathy compared to ischemic cardiomyopathy, and its differential expression was validated by qRT-PCR [Bonet et al. DOI:10.3390/biom14050524]. In a separate human study of older monozygotic twins, longitudinal analysis of plasma miRNAs associated the mir-487b with age-related functional decline, showing a negative beta coefficient indicating decreased functionality over time with higher baseline levels [La Grotta et al. DOI:10.1016/j.mad.2025.112099].